NCT00886327

Brief Summary

Up to ¾ of patients who have been diagnosed with Crohn's disease (CD) will have to undergo bowel resection during their lifetime despite modern medical therapies. Unfortunately, disease recurrence is common and endoscopic detection of recurring inflammation precedes clinical relapse. Endoscopic investigation is therefore recommended to manage these patients. This multi center, prospective study compares the conventional endoscopic method, ileo-colonoscopy to a new technique, i.e., colonic capsule endoscopy (CCE). CCE enables investigation of the small bowel and the large intestines by using a double-sided video camera with about 10 hours acquisition time. This study aims to evaluate the performance of CCE to detect postoperative recurrence of CD and detection rate of colonic and anastomotic recurrence is compared to ileo-colonoscopy. Proximal (small bowel) lesions are additionally recorded and impact on clinical management of the findings is accounted for. Moreover, safety aspects and influence of the findings on progress of the disease are monitored. All consecutive patients who are operated for CD in any of the participating study centers are eligible. Included are patients with segmental small bowel, ileocecal or segmental colonic resection. In some cases capsule retention has been reported at an average of 2-3% with CD patients at elevated risk. Therefore, patency capsule is performed before application of the video CCE to exclude bowel obstruction. Sample size estimation results in n = 70, requiring each 140 capsule endoscopes and 140 patency capsules for performance of postoperative screening (ca 4-8 weeks postoperatively) and detection of postoperative recurrence (ca 4-8 months postoperatively).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2009

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 22, 2009

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2009

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

May 31, 2012

Status Verified

April 1, 2009

Enrollment Period

3.6 years

First QC Date

April 21, 2009

Last Update Submit

May 30, 2012

Conditions

Keywords

Colonic capsule endoscopyCrohn's diseaseCapsule endoscopy

Outcome Measures

Primary Outcomes (1)

  • Detection of postoperative recurrence of CD

Secondary Outcomes (4)

  • Therapeutic intervention due to detection of recurrent CD

  • Detection of small bowel lesions by CCE

  • Rate of bowel stenosis as detected by PC

  • Side effect of CCE and/or colonoscopy

Study Arms (1)

Postoperative patients

Patients with CD who recently underwent bowel resection

Procedure: Colonic capsule endoscopy

Interventions

Postoperative patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients who are operated for CD in any of the participating study centers are eligible. Included are patients with segmental small bowel, ileocecal or segmental colonic resection. All patients have to give written informed consent before participating in the study.

You may qualify if:

  • Segmental bowel resection for Crohn's disease
  • Ileocecal resection
  • Small bowel resection
  • Segmental colonic resection
  • Informed consent
  • Age ≥ 18 years

You may not qualify if:

  • Intestinal obstruction as suspected by anamnesis or clinical/technical investigation
  • Dysphagia or ileus
  • Non-passage of the intact 'Agile Patency Capsule' within 72 hours
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Klinikum der JW Goethe Universität Frankfurt

Frankfurt am Main, Germany

RECRUITING

Medizinische Hochschule Hannover

Hanover, Germany

NOT YET RECRUITING

Universitaetsklnikum Leipzig

Leipzig, Germany

NOT YET RECRUITING

Klinikum der Universität München - Campus Grosshadern

München, Germany

NOT YET RECRUITING

MeSH Terms

Conditions

Crohn Disease

Interventions

Endoscopy

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Joerg G Albert, MD

    Johann Wolfgang Goethe University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joerg G Albert, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 21, 2009

First Posted

April 22, 2009

Study Start

May 1, 2009

Primary Completion

December 1, 2012

Study Completion

December 1, 2013

Last Updated

May 31, 2012

Record last verified: 2009-04

Locations